RecruitingNCT07662018
Prospective Observational Study of Outcomes After Gemcitabine, Docetaxel, Melphalan, and Carboplatin With Autologous Stem Cell Transplantation in Pediatric Relapsed/Refractory Germ Cell Tumors
Sponsor
M.D. Anderson Cancer Center
Enrollment
30 participants
Start Date
Jun 5, 2026
Study Type
OBSERVATIONAL
Conditions
Summary
To collect information about treatment outcomes in pediatric and adolescent patients with relapsed/refractory germ cells tumors who receive GemDMC with an ASCT.
Eligibility
Min Age: 21 Years
Plain Language Summary
Simplified for easier understanding
This clinical trial is studying a drug called Carboplatin, a drug called Docetaxel, and others for people with carboplatin, docetaxel, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 21 Years and older.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DRUGGemcitabine (GEM)
Give by Iv
DRUGDocetaxel
Given by Iv
DRUGMelphalan
Given by IV
DRUGCarboplatin
Given by Iv
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07662018
Related Trials
Perioperative Durvalumab With Neoadjuvant ddMVAC or Gemcitabine/Cisplatin in Patients With Muscle-invasive Bladder Cancer (NIAGARA-2)
NCT0696057759 locations
A Phase I Study Investigating the Combination of the Ziftomenib, Venetoclax and Azacitidine in Pediatric Relapsed and Refractory Acute Leukemias
NCT063970271 location
Adjuvant Oxaliplatin Plus S-1 Versus Docetaxel Plus S-1 for Stage III Gastric Cancer
NCT073665285 locations
A Clinical Study of Ultra-transplantation for the Treatment of Major Thalassemia Scheme
NCT067434771 location
Evaluation of Concomitant Chemo-radiotherapy With Cisplatine vs Gemcitabin in Locally Advanced Cervicouterine Cancer
NCT061565141 location